parkinson's disease news

AbbVie, Parkinson's disease

AbbVie's Parkinson's disease drug meets main goal in late-stage trial

AbbVie's drug met the main goal in a late-stage trial when tested in patients with early Parkinson's disease, the company said on Thursday.Patients showed a statistically significant improvement when two fixed doses of the drug,

FierceBiotech · 9h

AbbVie's dopamine-focused Parkinson's treatment reduces disease burden in phase 3 trial

AbbVie plans to share results from another phase 3 trial of tavapadon later this year, the pharma said in the release. That trial is testing the drug as a flexible-dose monotherapy.

Business Insider · 11h

AbbVie: Tavapadon Meets Primary, Secondary Endpoints In Phase 3 Trial In Early Parkinson's Disease

Drugmaker AbbVie (ABBV) announced Thursday positive topline results from its pivotal Phase 3 TEMPO-1 trial for tavapadon as a

MarketWatch · 11h

AbbVie: Tavapadon Meets Key Endpoints in Phase 3 Parkinson's Study

AbbVie on Thursday said a late-stage study of its recently acquired tavapadon drug candidate for the neurodegenerative disorder Parkinson's disease hit its key goals. AbbVie said tavapadon met the primary endpoint in the pivotal Phase 3 fixed-dose monotherapy trial,

Seeking Alpha · 11h

AbbVie Parkinson's disease therapy hits main goal in late-stage trial

AbbVie (ABBV) said its Phase 3 trial TEMPO-1 for experimental therapy Tavapadon reached main goal in Parkinson's disease. Read more here.

Brett Favre says he has Parkinson's disease

The Associated Press – Sports … · 22h

What to know about Parkinson’s disease after Brett Favre’s announcement

More than a decade after retiring from football, Brett Favre says he has Parkinson’s disease. Favre told a congressional hearing Tuesday that he had been recently diagnosed. There are nearly 90,000 new Parkinson’s cases each year in the U.S., according to the Parkinson’s Foundation.

The New York Times · 1d

What Is Parkinson’s Disease?

Brett Favre announced his diagnosis on Tuesday. Here’s what we know about the disease and its relationship to head injuries.

FOX 35 Orlando on MSN · 1d

Brett Favre has Parkinson's: What to know about the disease

NFL Hall of Famer Brett Favre announced on Tuesday that he has been diagnosed with Parkinson's disease. Dr. Vikram Shivkumar, a neurologist at Orlando Health Neuroscience Institute, shares how having multiple concussions can increase the risk for developing the disease.

Favre’s Parkinson’s disease diagnosis raises questions about link to football; UAB research might have answers

Researchers at UAB found blows to the head, like football players regularly experience, play a “significant” role in a person ...

Here's Everything You Need To Know About Parkinson's Disease, Including The Warning Signs And Who's Most At Risk

Former NFL player Brett Favre announced this week that he's been recently diagnosed with the condition. Here's what you ...

2don MSN

What Is Parkinson's Disease? Here Are The Warning Signs And Who's Most At Risk.

Former NFL player Brett Favre announced this week he's been recently diagnosed with the condition. Here's what to know.

Medical Moment: New blood test detects Parkinson’s disease

A tremor that won’t stop, slow movements, rigid muscles they’re the classic signs of Parkinson’s disease that alert doctors ...

Pitching for Parkinson's in Grand Chute provides insight and support to those living with disease

Pitching for Parkinson's in Grand Chute provides insight and support to those living with disease Max Matus, 18, says the ...

McKnight's Long-Term Care News47m

Promising results from Parkinson’s drug trial

Tavapadon, a drug made by AbbVie to treat Parkinson’s disease, met phase 3 TEMPO-1 trial goals treated early Parkinson's disease and improved motor skills, the company reported on Thursday.

Favre's Parkinson's diagnosis revives questions about link between football, brain disease

"It's hard to say or predict the future as to whether or not Brett Favre or other folks we maybe know in our community would ...

WGN Radio4h

What to know about Parkinson’s disease

Dr. Danielle Larson, Movement Disorders Specialist at Northwestern Medicine, joins Jon Hansen (in for Lisa Dent) to discuss ...

Unlocking the energy crisis in Parkinson's: New findings on metabolic disruptions

Parkinson's disease (PD), the second most common neurodegenerative disorder globally, has long baffled scientists with its ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Related topics